Clin Mol Hepatol.  2022 Oct;28(4):583-705. 10.3350/cmh.2022.0294.

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

• Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea

• KMID: 2534337
• DOI: http://doi.org/10.3350/cmh.2022.0294

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth most common cancer among men in South Korea, where the prevalence of chronic hepatitis B infection is high in middle and old age. The current practice guidelines will provide useful and sensible advice for the clinical management of patients with HCC. A total of 49 experts in the fields of hepatology, oncology, surgery, radiology, and radiation oncology from the Korean Liver Cancer Association-National Cancer Center Korea Practice Guideline Revision Committee revised the 2018 Korean guidelines and developed new recommendations that integrate the most up-to-date research findings and expert opinions. These guidelines provide useful information and direction for all clinicians, trainees, and researchers in the diagnosis and treatment of HCC.

Keyword

Diagnosis; Guidelines; Hepatocellular carcinoma; Management